Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11084
Title: DNA binding and antitumor activities of platinum(IV) and zinc(II) complexes with some S-alkyl derivatives of thiosalicylic acid
Authors: Besser Silconi Z.
Benazic S.
Milovanovic, Jelena
Jurisevic M.
Djordjevic, Dragana
Nikolic, Milos
Mijajlovic M.
Ratković, Zoran
Radic G.
Radisavljević, Snežana
Petrović, Biljana
Radosavljevic, Gordana
Milovanovic, Marija
Arsenijevic, Nebojsa
Issue Date: 2018
Abstract: © 2018, Springer Nature Switzerland AG. A series of complexes of platinum(IV) (C1–C5) and zinc(II) (C6–C10) with S-alkyl derivatives of thiosalicylic acid were prepared and characterized. The interactions of the complexes with calf thymus DNA were analyzed by absorption (UV–Vis) and emission spectral studies (ethidium bromide displacement studies). The cytotoxic activities of complexes C1–C10 were determined against mouse B cell lymphocytic leukemia cells (BCL1), human B-prolymphocytic leukemia (JVM-13), mouse mammary carcinoma cells (4T1), and human mammary carcinoma cells (MDA-MB-468) and compared to the activities of the free ligand precursors and cisplatin. The cytotoxicities of the platinum(IV) and zinc(II) complexes toward mouse tumor cell lines were higher compared with their effects on human tumor cell lines. The zinc(II) complex C9 showed the highest antitumor activity toward the tested human cell lines, while the platinum(IV) complex C4 exhibited the highest antitumor activity toward mouse BCL1 and 4T1 cells. Both C4 and C9 have ligands derived from S-propyl thiosalicylic acid.
URI: https://scidar.kg.ac.rs/handle/123456789/11084
Type: article
DOI: 10.1007/s11243-018-0260-2
ISSN: 0340-4285
SCOPUS: 2-s2.0-85050523399
Appears in Collections:Faculty of Medical Sciences, Kragujevac
Faculty of Science, Kragujevac

Page views(s)

226

Downloads(s)

8

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.